The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?

Rubina Marzagalli; Alessandro Castorina

首页> 外文期刊>Neural regeneration research >The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?

【24h】

The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?

机译：腺苷受体的似乎悖论作为治疗阿尔茨海默病的靶点：激动剂或拮抗剂？

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neural regeneration research 》 |2015年第2期| 共3页
作者
Rubina Marzagalli; Alessandro Castorina;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer’s disease：agonists or antagonists? [J] . Rubina Marzagalli, Alessandro Castorina 中国神经再生研究（英文版） . 2015 ,第002期

机译：腺苷受体看似悖论是治疗阿尔茨海默氏病的靶点：激动剂或拮抗剂？
2. Development of time-resolved fluorescent based [eu]-gtp binding assay for selection of human histamine 3 receptor antagonists/inverse agonist: a potential target for alzheimer’s treatment [J] . Singh, Jitendra Kumar, Maniyar, Annals of Neurosciences . 2012 ,第2期

机译：开发基于时间分辨荧光的[eu] -gtp结合测定以选择人类组胺3受体拮抗剂/反向激动剂：阿尔茨海默氏病的潜在治疗靶标
3. Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer's Disease [J] . Werner Felix-Martin, Covenas Rafael Current pharmaceutical design . 2016 ,第14期

机译：血清素能药物：特定血清素能亚受体的激动剂/拮抗剂，用于治疗阿尔茨海默氏病的认知，抑郁和精神病症状
4. Different inverse agonist activities ofbeta-adrenergic receptor antagonists-pharmacologicalcharacterization and therapeutical implicationsin the treatment of chronic heart failure [C] . Christoph Maack, Michael Bohm Fundaci髇 Dr. Antonio Esteve . 2003

机译：不同逆激动剂活性的β-肾上腺素能受体拮抗剂 - 药理特征和治疗意义治疗慢性心力衰竭
5. Adenosine receptor antagonists show promising results as an adjunctive treatment for Parkinson's disease. [D] . Vallance, Christopher S. 2007

机译：腺苷受体拮抗剂作为帕金森氏病的辅助治疗方法显示出令人鼓舞的结果。
6. Development of time-resolved fluorescent based EU-GTP binding assay for selection of human Histamine 3 receptor antagonists/inverse agonist: a potential target for Alzheimer’s treatment [O] . Jitendra K. Singh, Reema C. Maniyar, Vikas S. Shirsath 2012

机译：开发基于时间分辨荧光的EU -GTP结合测定法用于选择人组胺3受体拮抗剂/反向激动剂：阿尔茨海默氏症治疗的潜在目标
7. The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer′s disease: agonists or antagonists? [O] . Rubina Marzagalli, Alessandro Castorina 2015

机译：腺苷受体作为治疗阿尔茨海默病的靶点似乎悖论：激动剂或拮抗剂？

The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?

著录项

相似文献

相关主题

期刊订阅